QVT Financial LP

QVT Financial LP is a privately owned hedge fund sponsor based in New York, New York, with an additional office in London, United Kingdom. The firm provides its services to pooled investment vehicles, investing in public equity and debt markets worldwide. It also engages in alternative investment markets, including structured finance, private placements, high yield, and distressed debt, employing strategies such as convertible arbitrage, investment grade, and capital structure arbitrage techniques.

The firm's investment focus spans several sectors, including Biotech & Biopharmaceuticals, Healthcare Services, and Financial Services. QVT Financial LP operates across various stages of investment, including Growth, Late Stage, Pre-IPO, Buyout, Turnaround, and Distressed situations. Its geographical focus includes the United States and the United Kingdom.

QVT Financial LP originated as a non-traditional proprietary trading group within an investment bank. The core team has spent over 15 years working together to develop and implement innovative, fundamental, and idiosyncratic trading strategies, many of which make extensive use of internally developed, proprietary software. The firm's lean organization and entrepreneurial culture are reflected in its staffing philosophy, which emphasizes employing a select number of exceptionally high-caliber individuals who can apply original thinking to a wide range of investment opportunities across sectors and around the world.

QVT Financial LP's portfolio includes investments in companies such as GridPoint, Lightsynq Technologies, Active Surfaces, Kriya Therapeutics, AveXis, REGENXBIO, Ocera Therapeutics, Acceleron Pharma, Resolvyx Pharmaceuticals, and Concert Pharmaceuticals. These investments demonstrate the firm's commitment to diverse and strategic opportunities in the market.